2016

The Sixty Day Rule The Centers for Medicare and Medicaid Services (CMS) has finally issued its final rule related to…

Now that the year has gotten off to a quick start with all things healthcare-related, we would like to take a moment to…

Yesterday an FDA Advisory panel overwhelmingly recommended the Celltrion/Pfizer biosimilar Remsima 21-3 for approval for…

An increasing number of senators are threatening to block Dr. Robert Califf's nomination to be the next Commissioner of…

This year, Pharma IQ, a division of the International Quality and Productivity Center, will be hosting the Biosimilars…

Physicians are fed up with ERH, and are organizing with campaigns and creative music videos such as Let Doctors Be…

The February 2016 issue of Life Science Compliance Update, available here (subscription required), explores the impact…

The United States House Oversight and Government Reform Committee held a hearing on developments in the prescription…

In our latest endeavor to try to help you wade through the lengthy regulations known as Open Payments leading up to the…

Centers for Medicare and Medicaid Services is hosting an informal Question and Answer session on February 9, 2016, from…